statistiche ricercatore

Continente	#
NA - Nord America	421
AS - Asia	419
EU - Europa	209
SA - Sud America	71
AF - Africa	34
Continente sconosciuto - Info sul continente non disponibili	21
OC - Oceania	2
Totale	1.177

Nazione	#
US - Stati Uniti d'America	403
SG - Singapore	134
CN - Cina	95
VN - Vietnam	88
IT - Italia	83
BR - Brasile	52
BD - Bangladesh	33
HK - Hong Kong	28
DE - Germania	23
ZA - Sudafrica	20
SE - Svezia	19
FR - Francia	18
IE - Irlanda	18
CA - Canada	13
IN - India	11
AR - Argentina	9
NL - Olanda	9
GB - Regno Unito	7
ES - Italia	6
IQ - Iraq	5
RU - Federazione Russa	5
AT - Austria	4
EC - Ecuador	4
EG - Egitto	4
FI - Finlandia	4
JP - Giappone	4
PL - Polonia	4
TR - Turchia	4
TW - Taiwan	4
CI - Costa d'Avorio	3
CL - Cile	3
PH - Filippine	3
AL - Albania	2
KR - Corea	2
KZ - Kazakistan	2
MX - Messico	2
NG - Nigeria	2
TN - Tunisia	2
AU - Australia	1
AZ - Azerbaigian	1
BG - Bulgaria	1
CO - Colombia	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
HU - Ungheria	1
ID - Indonesia	1
IR - Iran	1
LT - Lituania	1
LV - Lettonia	1
LY - Libia	1
MA - Marocco	1
MY - Malesia	1
NZ - Nuova Zelanda	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
SN - Senegal	1
SV - El Salvador	1
TH - Thailandia	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.157

Nome	#
SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy	187
The aflatox® project: Approaching the development of new generation, natural‐based compounds for the containment of the mycotoxigenic phytopathogen Aspergillus flavus and aflatoxin contamination	177
Antiaflatoxigenic Thiosemicarbazones as Crop-Protective Agents: A Cytotoxic and Genotoxic Study	162
Use of FTA® classic cards for epigenetic analysis of sperm DNA	155
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing	153
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)	134
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents	108
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)	101
Totale	1.177

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	23	0	0	0	0	0	1	8	3	3	2	1	5
2022/2023	80	8	9	7	9	5	11	0	5	22	1	2	1
2023/2024	56	1	0	1	0	4	9	3	4	1	14	13	6
2024/2025	219	15	9	14	15	19	20	10	12	23	19	17	46
2025/2026	729	63	85	106	77	67	38	53	33	85	43	38	41
2026/2027	27	12	15	0	0	0	0	0	0	0	0	0	0
Totale													1.177